McCamish Mark Anthony 4
4 · AVADEL PHARMACEUTICALS PLC · Filed Jul 31, 2025
Insider Transaction Report
Form 4
McCamish Mark Anthony
Director
Transactions
- Award
Ordinary Shares
2025-07-29+11,000→ 22,000 total - Award
Stock Option (Right to Buy)
2025-07-29+11,000→ 11,000 totalExercise: $10.83Exp: 2035-07-29→ Ordinary Shares (11,000 underlying)
Holdings
- 67,025(indirect: By LLC)
Ordinary Shares
Footnotes (3)
- [F1]Represents a restricted share award. The shares shall vest in full on the earlier to occur of (a) July 29, 2026 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service at such time.
- [F2]Shares held by Matthew 5 LLC. The Mark & Barbara McCamish Family Trust is the sole owner of Matthew 5 LLC, and the Reporting Person serves as its manager.
- [F3]The options shall vest in full on the earlier to occur of (a) July 29, 2026 or (b) the date of the next annual general meeting of shareholders following the date of grant, subject to the Reporting Person's continued service at such time.